Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 409
Selected: 0
NCT IDTitle
NCT00724022Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation
NCT01126866Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy
NCT06634225Use of Inertial Units in Patient With Multiple Sclerosis (IMUSEP)
NCT03654833Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma
NCT04387890Serologic Surveillance for SARS-CoV-2 (COVID-19) in a Prospective Cohort of Health Care Workers
NCT04400474Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study
NCT00865982Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer
NCT01523340A Prospective Observational Study Evaluating c-MET Expression and EGFR Gene Mutation Correlation With Erlotinib Response
NCT04490044Under and Over Rehabilitation Study
NCT01565200HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1
NCT03961698Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
NCT01303887A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
NCT00223301Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis
NCT01015339Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
NCT01847677Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin
NCT04611867Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)
NCT00275548Safety and Effectiveness Using Pegasys and Copegus in Recipients of Liver Transplantation With Hepatitis C
NCT02169349Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer
NCT00476164Study of Rituximab to Treat Chronic Renal Transplant Rejection
NCT00719264Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
NCT02758665Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL
NCT04332822A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
NCT01172392A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
NCT04059887Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]
NCT02303119Follicular Lymphoma IV/SC Rituximab Therapy (FLIRT)
NCT00201734Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary
NCT01745965A Prospective, Randomized Multicenter, Open-label Comparison of Preoperative Trastuzumab Emtansine (T-DM1) With or Without Standard Endocrine Therapy vs. Trastuzumab With Standard Endocrine Therapy Given for Twelve Weeks in Patients With Operable HER2+/HR+ Breast Cancer Within the ADAPT Protocol.
NCT02120911Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma
NCT05798312Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material
NCT00769522FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
NCT035905355th Generation cTnT in ED ACS
NCT00411762A Phase I/II, Multi-Center, Open-Label, Dose-Escalation, Safety and Efficacy Study of PHY906 Plus Capecitabine in Patients With Advanced Pancreatic Carcinoma
NCT01569984Radiosensitization of AVASTIN® (Bevacizumab) With Stereotactic Body Radiotherapy for Colorectal Liver Metastasis
NCT04641676A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center
NCT00170170Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation
NCT00626197A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)
NCT01456312HBsAg Related Response Guided Therapy
NCT03341520Gazyvaro and Low Dose Radiotherapy in Early Stage Follicular Lymphoma
NCT01306409Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)
NCT00333437Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement
NCT00079053Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00095901Capecitabine For Nasopharyngeal Cancer
NCT04808245A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas
NCT01167049Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis
NCT00438152Lopinavir Capsules to Kaletra or Invirase Tablets
NCT00384566A Comparison of the Effect of Carvedilol and Metoprolol on Airways Tone in Patients With Heart Failure
NCT01640405Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells
NCT00694408A Pilot Trial of Pediatric Liver Transplantation Without Steroids
NCT00405587Safety Study of PLX4032 in Patients With Solid Tumors
NCT01423695Weekly Paclitaxel and Trastuzumab in Metastatic Breast Cancer